New hope for dialysis patients battling severe anemia
NCT ID NCT07494409
Summary
This study is testing a new drug called AND017 to see if it can safely and effectively manage anemia (low red blood cells) in people with end-stage kidney disease who require dialysis. It will compare AND017 to an existing standard treatment over about a year. The main goal is to see if AND017 can better maintain healthy hemoglobin levels, which carry oxygen in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA DUE TO CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan Univeristy Zhongshan Hospital
RECRUITINGShanghai, 200032, China
Contact
Conditions
Explore the condition pages connected to this study.